Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Electro: Oral Levosimendan in Recent Stroke or TIA
NCT00698763Phase 2Completed
- Sponsor
- Orion Corporation
- Start
- Aug 2008
- Primary completion
- Apr 2009
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of levosimendan in ischemic stroke, Transient Ischemic Attack (TIA), sponsored by Orion Corporation. Started Aug 2008; status: completed.
02
Drugs
levosimendan
03
Conditions
ischemic strokeTransient Ischemic Attack (TIA)
Beyond the preview
Go deeper on NCT00698763.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00698763.